Leslie J. Crofford

Publication List Details

Period

1996 - 2008

Number

30

Co-Authors

Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome (2008)

Dadabhoy, Dina, Crofford, Leslie J, Spaeth, Michael, Russell, I Jon, Clauw, Daniel J

Abstract Researchers studying fibromyalgia strive to identify objective, measurable biomarkers that may identify susceptible individuals, may facilitate diagnosis, or that parallel activity of the...

Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia (2005)

Kocheril, Sosa V., Appleton, Brent E., Somers, Emily C., Kazerooni, Ella A., Flaherty, K. R., Martinez, Fernando J., ...

Objective To compare disease progression and mortality between idiopathic interstitial pneumonia (IIP) and interstitial lung disease (ILD) due to connective tissue diseases (CTD) including...

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2 (2005)

Sampey, Annaleise V, Monrad, Seetha, Crofford, Leslie J

Abstract Microsomal prostaglandin E synthase-1 (mPGES-1) is an inducible enzyme that catalyzes the conversion of prostaglandin (PG)H 2 to PGE 2 . Proinflammatory stimuli markedly increase levels of...

Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial (2005)

Crofford, Leslie J., Rowbotham, Michael C., Mease, Philip J., Russell, I. Jon, Dworkin, Robert H., Corbin, Ann E., ...

Objective Fibromyalgia syndrome (FMS) is characterized by widespread musculoskeletal pain and lowered pain threshold. Other prominent symptoms include disordered sleep and fatigue. FMS affects an...

Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2 (2005)

Crofford, Leslie J., McDonagh, Kevin T., Guo, Sutang, Mehta, Hemal, Bian, Huimin, Petruzelli, Lilli M., ...

Background Recombinant adenovirus can be administered in vivo to achieve transduction of a number of cell types including human synoviocytes. Immunogenicity of adenoviruses has limited their utility...

COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease (2002)

Crofford, Leslie J

Abstract The use of analgesic anti-inflammatory agents in patients with asthma is clinically challenging because of the prevalence (10–20%) of aspirin hypersensitivity. Aspirin-exacerbated...

Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatant (2002)

Yang, Jianmin, Friedman, Michael S, Bian, Huimin, Crofford, Leslie J, Roessler, Blake, McDonagh, Kevin T

Abstract We are developing retroviral-mediated gene transfer to human fibroblast-like synovial cells (FLS) as one approach to characterizing genetic pathways involved in synoviocyte pathophysiology....

Cognitive function in fibromyalgia patients (2001)

Park, Denise C., Glass, Jennifer M., Minear, Meredith, Crofford, Leslie J.

Objective To evaluate fibromyalgia (FM) patients for the presence of cognitive deficits and to test the hypothesis that abnormalities would fit a model of cognitive aging. Methods We studied 3 groups...

Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors: A report of four cases (2000)

Crofford, Leslie J., Oates, James C., McCune, William Joseph, Gupta, Samardeep, Kaplan, Mariana J., Catella-Lawson, Francesca, ...

Specific inhibitors of cyclooxygenase 2 (COX-2) have been approved for the treatment of osteoarthritis and rheumatoid arthritis. Unlike nonsteroidal anti-inflammatory drugs, specific COX-2 inhibitors...

The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome (1998)

Crofford, Leslie J.

HPA axis abnormalities in FM, CFS, and other stress-related disorders must be placed in a broad clinical context. We know that interventions providing symptomatic improvement in patients with FM and...

Involvement of nuclear factor k B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes (1997)

Crofford, Leslie J., Tan, Bing, McCarthy, Conor J., Hla, Timothy

Objective . To evaluate involvement of the transcription factor nuclear factor k B (NF- k B) in the increased expression of cyclooxygenase-2 (COX-2) stimulated by interleukin-1Β (IL-1Β) in primary...

Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes (1996)

Tsai, Carlene, Diaz, Luis A., Singer, Nora G., Li, Lan Lan, Kirsch, Anita H., Mitra, Raj, ...

Objective . Type B fibroblastic synoviocytes are abundant in inflamed joints of patients with rheumatoid arthritis (RA), and can secrete cytokines and other mediators of inflammation. The aim of this...

Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatant

Yang, Jianmin, Friedman, Michael S, Bian, Huimin, Crofford, Leslie J, Roessler, Blake, McDonagh, Kevin T

We are developing retroviral-mediated gene transfer to human fibroblast-like synovial cells (FLS) as one approach to characterizing genetic pathways involved in synoviocyte pathophysiology. Prior...

COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease

Crofford, Leslie J

The use of analgesic anti-inflammatory agents in patients with asthma is clinically challenging because of the prevalence (10–20%) of aspirin hypersensitivity. Aspirin-exacerbated respiratory...

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2

Sampey, Annaleise V, Monrad, Seetha, Crofford, Leslie J

Microsomal prostaglandin E synthase-1 (mPGES-1) is an inducible enzyme that catalyzes the conversion of prostaglandin (PG)H2 to PGE2. Proinflammatory stimuli markedly increase levels of mPGES-1...

Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatant

Yang, Jianmin, Friedman, Michael S, Bian, Huimin, Crofford, Leslie J, Roessler, Blake, McDonagh, Kevin T

We are developing retroviral-mediated gene transfer to human fibroblast-like synovial cells (FLS) as one approach to characterizing genetic pathways involved in synoviocyte pathophysiology. Prior...

COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease

Crofford, Leslie J

The use of analgesic anti-inflammatory agents in patients with asthma is clinically challenging because of the prevalence (10–20%) of aspirin hypersensitivity. Aspirin-exacerbated respiratory...

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2

Sampey, Annaleise V, Monrad, Seetha, Crofford, Leslie J

Microsomal prostaglandin E synthase-1 (mPGES-1) is an inducible enzyme that catalyzes the conversion of prostaglandin (PG)H2 to PGE2. Proinflammatory stimuli markedly increase levels of mPGES-1...

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

Nash, Richard A., McSweeney, Peter A., Crofford, Leslie J., Abidi, Muneer, Chen, Chien-Shing, Godwin, J. David, ...

More effective therapeutic strategies are required for patients with poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose immunosuppressive therapy (HDIT) and autologous...

Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome

Dadabhoy, Dina, Crofford, Leslie J, Spaeth, Michael, Russell, I Jon, Clauw, Daniel J

Researchers studying fibromyalgia strive to identify objective, measurable biomarkers that may identify susceptible individuals, may facilitate diagnosis, or that parallel activity of the disease....